Comparative activity of oral and parenteral cephalosporins tested against multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1997–2003)
Authors:
- Thomas R. FritscheTFThomas R. Fritsche
- Ronald N. JonesRJRonald N. Jones
- 1 February 2005
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 51 (2) , 147-150
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Drug‐Resistant Pneumococcal Pneumonia: Clinical Relevance and Related FactorsClinical Infectious Diseases, 2004
- The activity of levofloxacin and other antimicrobials against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999-2002Diagnostic Microbiology and Infectious Disease, 2003
- Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent AdultsClinical Infectious Diseases, 2003
- Comparative activity and spectrum of broad-spectrum β-lactams (cefepime, ceftazidime, ceftriaxone, piperacillin/tazobactam) tested against 12,295 staphylococci and streptococci: report from the SENTRY antimicrobial surveillance program (North America: 2001-2002)Diagnostic Microbiology and Infectious Disease, 2003
- Comparison of Streptococcus pneumoniae and Haemophilus influenzae susceptibilities from community-acquired respiratory tract infections and hospitalized patients with pneumonia: five-year results for the SENTRY antimicrobial surveillance programDiagnostic Microbiology and Infectious Disease, 2003
- Increasing Prevalence of Multidrug-ResistantStreptococcus pneumoniaein the United StatesNew England Journal of Medicine, 2000